Gene expression profiling identifies clinically relevant subtypes of prostate cancer. - Wikidata - wikimedia - TriplyDB

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

http://www.wikidata.org/entity/Q35554359

about

Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein over-expression in human prostate cancer tissue LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer Evaluation of protein biomarkers of prostate cancer aggressiveness On the selection of appropriate distances for gene expression data clustering A minimal fragment of MUC1 mediates growth of cancer cells An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer Possible role of death receptor-mediated apoptosis by the E3 ubiquitin ligases Siah2 and POSH Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteins CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer HPtaa database-potential target genes for clinical diagnosis and immunotherapy of human carcinoma.Sample size for detecting differentially expressed genes in microarray experiments.Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer Differential expression of anterior gradient gene AGR2 in prostate cancer Mucins in cancer: function, prognosis and therapy Advances in translational bioinformatics: computational approaches for the hunting of disease genes The role of SPINK1 in ETS rearrangement-negative prostate cancers Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling Iterative class discovery and feature selection using Minimal Spanning Trees A DNA microarray survey of gene expression in normal human tissues.GeneXplorer: an interactive web application for microarray data visualization and analysis Semi-supervised methods to predict patient survival from gene expression data Storing, linking, and mining microarray databases using SRS An improved procedure for gene selection from microarray experiments using false discovery rate criterion.The mutational landscape of prostate cancer Emerging critical role of molecular testing in diagnostic genitourinary pathology Lipid metabolism in prostate cancer Osteoprotegerin in bone metastases: mathematical solution to the puzzle Acquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypes Clustering cancer gene expression data: a comparative study The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3 Role of the TMPRSS2-ERG gene fusion in prostate cancer ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferation Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition

P2860

Q21132372-6D754C02-1314-4AAA-BE44-3483C33FDBAC Q21202034-CE878872-0C5B-48F5-A31E-0F0DEFEB8F3B Q21261257-22077E0E-E49C-4069-9644-B864E38513F9 Q21284299-46705B9B-3863-491F-B2B0-513993E14A64 Q21562292-82673FCE-99B9-4CA4-B862-26A46B2F95D7 Q24299235-9415B583-684D-4F1A-BBB0-C8226BC29DF8 Q24301832-A62C1449-013B-4E64-982A-1CB624F38252 Q24302687-77A3FABC-6B49-439A-9F8A-8400DFCF7FB5 Q24303547-42071363-379C-4A73-AC83-EC65509D1DBF Q24309409-2887250E-8F9C-40A7-9B58-967E42764F8F Q24320341-AF592A92-06D5-4D83-8B32-A362250BC0EC Q24528253-F8F5BDE7-81C3-4DC4-893D-A646DFDADB41 Q24538578-9E02E459-82FF-4B95-94DF-E313A55CEDD4 Q24559823-2D3A7498-62A3-4496-88EE-7F1CEC1D1223 Q24610167-F38806F5-D99D-43F8-BC5D-214EAEE0FF41 Q24622298-6526520B-A8B8-4FB0-8EEC-E4A796EBDBA7 Q24633765-B5293A08-56B5-4DCE-B459-81D07D261299 Q24642050-65DFF30B-8A45-4DA0-81E2-DBD71309C410 Q24647020-DAEFFD72-4A89-4664-90A6-AC9B172998BE Q24649955-74B5776E-EFDF-4E11-9B98-29E7412C17AE Q24676201-9912AA02-8728-45DC-8A1C-68824E16007F Q24677061-AD6F3A1E-4BEE-446E-8B20-86858889002B Q24795482-5F5C8284-8B8E-4B5D-B2C2-AF10BA180F13 Q24797220-FFDC8131-0FB8-4F5F-AF10-79B14853CFF7 Q24802721-89EB817D-903A-4A4D-86EA-0384234A2FEE Q24804682-9D986C97-8FC4-4A24-8972-8871706B9E35 Q24813666-334FE129-7CA1-4468-8CA2-DD0C6F8297AD Q25255568-AA4C7258-0CFA-45E0-8213-2AFE3216B38B Q26851631-3158A65C-B134-486D-AA40-8C331FCE20A0 Q27021371-829894FC-7775-419F-8CE3-7608F3929E8E Q27025766-FB92BF70-DB3E-4FC2-9853-0A9A7C6DFACB Q27329714-D0CDDF84-9197-4DCB-B8F8-2BF8B73089CB Q27333989-15865B16-F486-480B-981E-F7A9ED5E0A72 Q27496523-3524965E-F2B4-4CB5-98D5-40FE92D29323 Q28242719-15821C20-EE03-408D-BB28-BD67F636C55D Q28269156-9C7DD6C5-0A69-491C-A1E0-F80AE9E8AA64 Q28289188-3014FBB0-0480-4CC4-ACBF-EAA1FFCC0122 Q28302520-E0E7694D-D249-40C6-A9F4-A921038281AA Q28391523-6ED0EF8C-55AF-445E-9285-F0C5D4EAFC3F Q28477123-1DFAB774-A790-42CC-8B8B-EE036B229283

P2860

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

http://www.wikidata.org/entity/Q35554359

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

@ast

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

@en

type

label

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

@ast

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

@en

prefLabel

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

@ast

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

@en

P1433

Q35554359-3F4E7B03-3260-4D36-96A3-F0AE106335FC

P1476

Q35554359-A46C8EC1-9DFF-4FB1-9AA1-36B6D49CF08E

P2093

Q35554359-22C694AC-88E8-4BFC-9CEF-F13E8E4C1F79

Q35554359-3DE71DEA-A146-49A8-B9F0-DF35C8BDB298

Q35554359-487DF183-DCF9-4485-86E9-AC0A4E51FE93

Q35554359-551100C1-25BB-418F-9F3B-0B44F8707236

Q35554359-5EAB970E-B733-4E17-A4AC-3F15CC2BC33C

Q35554359-748CE911-EB9B-42D1-B699-963B445FC1EE

Q35554359-9FCA40F3-4A4F-4A59-87A6-BF228A72438E

Q35554359-A7110EBC-B982-441F-BFDE-96666727FD76

Q35554359-CABC67C6-C212-4FB2-9FB8-47DE65D76CFB

P2860

Q35554359-087C9BC3-D2C2-4585-BAA3-B4DCA62D7823

Q35554359-08CC3BA9-CAB1-447B-974C-506A24076E48

Q35554359-10B23AEB-D671-4E19-9078-D04761585E3A

Q35554359-1679EA2B-C5B9-4131-A60D-2E92C8E1ADF2

Q35554359-16D855A2-06CC-4A91-A871-F30734918451

Q35554359-19BF12A8-23E0-4FE2-9E16-809991166AF9

Q35554359-25377836-29AC-492D-9BC2-AD693AC42799

Q35554359-28DE1C65-EEE1-42D4-8C61-7D969BBEC580

Q35554359-310CC502-2955-4A5E-A422-D3D1FFD03E08

Q35554359-3D9F935A-CFB8-4D05-AD60-6472F00BD193

P304

Q35554359-86903F09-00A7-46F8-B6AC-60B4754941F8

P31

Q35554359-80B1AC78-891E-49A2-9B91-F3640C30A3B8

P356

Q35554359-922621F2-8404-46EB-A958-0824F8701F36

P407

Q35554359-BDED1FEC-9503-4893-8D74-921A2FDF1CC4

P433

Q35554359-62C551E7-5AE6-47DC-A597-4B6FE0AD8DF5

P478

Q35554359-B7FEFA16-06CE-4FCA-9293-38EBCA8F177B

P50

Q35554359-0EA9E133-2FB2-4BAD-8C18-F0FEB505AA28

Q35554359-104BE662-DE66-4C62-ABA4-F99789C92EFA

Q35554359-70E7C784-B7D1-458E-9C81-541BEDD69CE4

Q35554359-83CBC4DF-5645-4EB5-9A71-F596110CBB13

Q35554359-855FE27C-D481-4062-81A0-31D0C2351614

Q35554359-DB8537A9-7F8A-40A5-9476-14E95963920F

Q35554359-E08CB2C8-E235-4F77-86CF-7A276C635CBB

Q35554359-E89266B5-7B2D-45EE-9F49-7CD6C3D894B3

P577

Q35554359-99F89C18-1397-4AFE-817C-4FAD19384876

P5875

Q35554359-E17F0BB7-EB92-4D0F-BD8D-83EE8FFEC55C

P698

Q35554359-23BA95CF-EEB6-4219-9F82-80211321147D

P932

Q35554359-DF5B3DA6-8184-407A-ADDE-98ED6DEFC138

P356

PNAS.0304146101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

@en

P2093

Angelo M DeMarzo

http://www.w3.org/2001/XMLSchema#string

Jacques Lapointe

http://www.w3.org/2001/XMLSchema#string

James D Brooks

http://www.w3.org/2001/XMLSchema#string

John P Higgins

http://www.w3.org/2001/XMLSchema#string

Kelli Montgomery

http://www.w3.org/2001/XMLSchema#string

Michelle Ferrari

http://www.w3.org/2001/XMLSchema#string

Peter Ekman

http://www.w3.org/2001/XMLSchema#string

Ulf Bergerheim

http://www.w3.org/2001/XMLSchema#string

Walter Rayford

http://www.w3.org/2001/XMLSchema#string

P2860

Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components

Significance analysis of microarrays applied to the ionizing radiation response

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

Molecular portraits of human breast tumours

Cell surface tumor endothelial markers are conserved in mice and humans

A molecular role for lysyl oxidase in breast cancer invasion

Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues

Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium

P304

811-816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0304146101

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Robert Tibshirani

Patrick O. Brown

Matt van de Rijn

Jonathan R. Pollack

P577

2004-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8928598

http://www.w3.org/2001/XMLSchema#string

P698

14711987

http://www.w3.org/2001/XMLSchema#string

P932

321763

http://www.w3.org/2001/XMLSchema#string